THC–CBD Sleep Findings Differed Between the Night and the Following Morning
A small crossover study summarized in the review did not find improved nocturnal sleep with THC alone, yet reported next-morning effects. THC–CBD combinations produced a different sleep pattern. Feeling sleepy afterward should not be substituted for evidence of better sleep overnight.
The experiment compared several oromucosal treatments
Eight participants received placebo, THC alone, or lower- and higher-dose THC–CBD combinations. The design included both nocturnal sleep measures and assessments after waking. These are related outcomes, but the study’s value depends on preserving their separate timing and definitions.
THC alone had a sleep null alongside morning signals
The review reports no nocturnal sleep effect with the tested THC-alone dose. The following morning, participants reported greater sleepiness shortly after rising, with changes in mood and selected memory measures. Those findings do not support describing the intervention as uniformly beneficial simply because it produced sleepiness.
The combinations did not reproduce every THC-alone result
THC–CBD combinations reduced slow-wave sleep, and the higher combination increased wakefulness. Morning effects also differed by combination: the lower combination did not show the same mood, sleepiness, fatigue or general performance changes reported with the higher combination. The review describes largely null memory comparisons for combinations, apart from a specific digit-recall reaction-time finding at the lower dose.
The sample limits product and clinical conclusions
Eight participants and acute laboratory conditions cannot settle treatment of chronic insomnia. The combination doses also prevent treating every difference as a clean CBD-only effect. The useful interpretation follows each outcome through the night and morning, retaining both significant observations and null comparisons. It does not supply a universally restorative cannabinoid formula or a next-day driving clearance.
Related analysis: the evidence gap in human cognitive-aging claims.
Research cited
This analysis uses the research synthesis in Heal DJ, Gosden J and Smith SL (2024), A critical assessment of the abuse, dependence and associated safety risks of naturally occurring and synthetic cannabinoids, Frontiers in Psychiatry.
The study discussed in that review is also identified by DOI: 10.1097/01.jcp.0000125688.05091.8f.
